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Abstract 
Background: Outer membrane vesicles (OMVs) are nanoparticles released by Gram-negative bacteria and can be 
used as vaccines. Often, detergents are used to promote release of OMVs and to remove the toxic lipopolysaccharides. 
Lipopolysaccharides can be detoxified by genetic modification such that vesicles spontaneously produced by bac-
teria can be directly used as vaccines. The use of spontaneous OMVs has the advantage that no separate extraction 
step is required in the purification process. However, the productivity of spontaneous OMVs by bacteria at optimal 
growth conditions is low. One of many methods for increasing OMV formation is to reduce the linkage of the outer 
membrane to the peptidoglycan layer by knocking out the rmpM gene. A previous study showed that for Neisseria 
meningitidis this resulted in release of more OMVs. Furthermore, cysteine depletion was found to trigger OMV release 
and at the same time cause reduced growth and oxidative stress responses. Here we study the effect of growth rate 
and oxidative stress on OMV release.
Results: First, we identified using chemostat and accelerostat cultures of N. meningitidis that increasing the growth 
rate from 0.03 to 0.18 h−1 has a limited effect on OMV productivity. Thus, we hypothesized that oxidative stress is 
the trigger for OMV release and that oxidative stress can be introduced directly by increasing the dissolved oxygen 
tension of bacterial cultures. Slowly increasing oxygen concentrations in a N. meningitidis changestat showed that an 
increase from 30 to 150% air saturation improved OMV productivity four-fold. Batch cultures controlled at 100% air 
saturation increased OMV productivity three-fold over batch cultures controlled at 30% air saturation.
Conclusion: Increased dissolved oxygen tension induces the release of outer membrane vesicles in N. meningitidis 
cultures. Since oxygen concentration is a well-controlled process parameter of bacterial cultures, this trigger can be 
applied as a convenient process parameter to induce OMV release in bacterial cultures. Improved productivity of 
OMVs not only improves the production costs of OMVs as vaccines, it also facilitates the use of OMVs as adjuvants, 
enzyme carriers, or cell-specific drug delivery vehicles.
Keywords: Outer membrane vesicles, Neisseria meningitidis, Oxidative stress, Dissolved oxygen changestat, 
Accelerostat
© The Author(s) 2018. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creat iveco mmons .org/licen ses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creat iveco mmons .org/
publi cdoma in/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Open Access
Microbial Cell Factories
*Correspondence:  michiel.stork@intravacc.nl 
1 Process Development Bacterial Vaccines, Institute for Translational 
Vaccinology (Intravacc), P.O. Box 450, 3720 AL Bilthoven, The Netherlands
Full list of author information is available at the end of the article
Page 2 of 10Gerritzen et al. Microb Cell Fact  (2018) 17:157 
Background
Outer membrane vesicles (OMVs) are naturally produced 
by Gram-negative bacteria and play a role in pathogen-
esis, cell-to-cell communication and stress responses 
[1]. OMVs are spherical nanoparticles that consist of a 
phospholipid bilayer with proteins and lipopolysaccha-
rides (LPS) [1]. The lumen of the vesicle contains DNA 
and periplasmic components of the bacterium [2, 3]. 
Membrane vesicle formation has been shown recently in 
Gram-positive bacteria and archaea as well [4, 5].
OMVs are highly similar to the outer membrane of 
the bacteria, are non-replicating, and characteristically 
are full of pathogen associated molecular patterns. With 
this they fulfill major criteria for vaccine design and have 
been successfully used as such [6, 7]. These vaccines have 
been produced by extraction of vesicles from the bacte-
rial outer membrane using detergents. In this way, vesi-
cles are artificially formed and the amount of toxic LPS 
could be reduced [8, 9]. However, extraction of vesicles is 
disadvantageous since the proteome of extracted OMVs 
(eOMVs) shows a lowered amount of possible immu-
nogenic proteins over spontaneously released OMVs 
(sOMVs) [10, 11]. Furthermore, extraction methods are 
not required anymore for LPS removal since the intro-
duction of genetically modified low toxicity LPS [12, 
13], which forms the basis for the use of spontaneously 
released OMV. Thus, the use of spontaneous released 
vesicles simplifies the purification of OMVs since it obso-
letes the extraction step in the down-stream processing 
of the vaccine product [10, 11]. Sera from mice immu-
nized with spontaneous OMVs show immunity against 
a broader range of serotypes than mice immunized with 
detergent extracted OMVs [14]. Furthermore, omission 
of detergent also preserves vesicle integrity, yielding a 
more uniform vaccine product.
Feasible sOMV production has not been straightfor-
ward since sOMV productivity at optimal growth con-
ditions is low. Despite the research on OMV biogenesis 
over the past 4 decades, the exact mechanism triggering 
the release of OMVs by a bacterium remains unknown. 
Because the composition of OMVs differs from the outer 
membrane of the bacteria, it is generally thought that 
the release of vesicles is not a random process [15]. Bio-
genesis of OMVs has been described by several models 
although it remains unclear whether a shared mechanism 
exists [16]. OMV biogenesis is hypothesized to be based 
on peptidoglycan fragments accumulation in the peri-
plasm, less anchoring of the outer membrane to the pep-
tidoglycan layer, or O-antigen charge repulsion. These 
models are reviewed in [17] and [2]. Recently, Roier et al. 
suggested a novel mechanism based on phospholipid 
accumulation that is conserved among Gram-negative 
bacteria [18]. The proposed phospholipid transporter 
VacJ/Yrb ATP-binding cassette was shown to be involved 
in OMV production and could be part of regulated OMV 
release. Increasing the OMV production by Neisseria 
meningitidis is possible by deleting the rmpM gene, the 
product of which anchors the outer membrane to the 
peptidoglycan layer [14]. Reducing the linkage between 
the outer membrane and the peptidoglycan layer results 
in so-called blebbing mutants of bacteria that show 
increased release of OMVs in the supernatant. This was 
found not only for N. meningitidis, but also for E. coli 
[19].
External triggers for OMV release could be a conveni-
ent way to enhance production in bioreactor cultures. 
Van de Waterbeemd et al. showed that cysteine depletion 
can be used as a trigger to stimulate the release of vesi-
cles in N. meningitidis cultures [20]. Simultaneously with 
cysteine depletion, the growth rate is reduced and oxida-
tive stress responses were observed in the transcriptome 
of the bacterium. It is unknown whether cysteine directly 
triggers OMV formation or works indirectly through 
a reduction in growth rate and/or increase in oxida-
tive stress. Furthermore, increased release of vesicles 
under hydrogen peroxide addition has been shown [20]. 
The method of hydrogen peroxide addition, however, is 
not feasible for scalable production processes of OMV 
since local hydrogen peroxide addition to a bacterial cul-
ture will result in significant cell death and lysis. In this 
study we hypothesize that extracellular oxidative stress is 
directly induced by high concentrations of dissolved oxy-
gen, which is one of the controlled parameters in bioreac-
tor cultivations. The dissolved oxygen tension is typically 
kept low, to minimize the stress from hyperoxia and to 
prevent oxygen inhibition [21]. Especially for a faculta-
tive anaerobic pathogen it is obvious to design the culti-
vation with low oxygen concentration [22]. For example, 
N. meningitidis cultivation for both the vaccine concepts 
HexaMen and NonaMen has been designed with levels of 
30% air saturation [23, 24].
The aim of this study is to obtain more insight in the 
role of growth rate and oxidative stress in the release 
of OMVs. The first section of this paper will examine 
whether a decrease in growth rate can trigger OMV 
release by using accelerostat experiments. Next, oxidative 
stress is introduced in continuous cultures by increasing 
the dissolved oxygen tension. Lastly, increasing the dis-
solved oxygen concentration is tested on batch cultures.
Results
Neisseria meningitidis sOMV release at reduced growth rate
The increased productivity of OMVs during the station-
ary phase of a batch cultivation [20] raised the ques-
tion what the direct influence of the growth rate on the 
sOMV release was. Here we assessed the influence of 
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growth rate on sOMV release in three chemostat cul-
tures in steady state at different dilution rates, and in an 
accelerostat, by slowly increasing the dilution rate of a 
chemostat culture of N. meningitidis. The slow change in 
dilution rate (aD) should keep the culture in steady state 
in this approach [25]. In this accelerostat an accelera-
tion rate (aD) of 0.0055 h−2 was used (Fig. 1b). The car-
bon dioxide evolution rate (CER) and the optical density 
increased simultaneously with the dilution rate (Fig. 1a). 
In the accelerostat, OMVs were produced during the 
whole culture and were also similar in size and protein 
composition throughout the culture (Fig. 1c, d). The spe-
cific sOMV production was constant throughout the cul-
ture with the growth rate ranging from 0.03 to 0.18 h−1 
(Fig.  1b). Chemostat cultures at three different growth 
rates showed comparable productivity to the accelerostat 
at a growth rate of 0.18 h−1, while the two lower growth 
rates show a minor increase in OMV productivity. From 
these results, we conclude that reducing the growth rate 
from 0.18 to 0.03  h−1 is not an important trigger for 
sOMV release.
Influence of oxidative stress in a dissolved oxygen tension 
changestat
The effect of increased oxygen concentration on bacterial 
growth and OMV release was assessed with a changestat 
approach. The dissolved oxygen tension of a chemostat 
culture is linearly increased at a rate (1%/h) that should 
be sufficient low to maintain a steady state culture 
(Fig. 2a). N. meningitidis is capable of growth up to 150% 
air saturation without significant impact on the carbon 
dioxide evolution rate (Fig. 2b). The release of sOMVs is 
linearly linked to the concentration of oxygen in the cul-
ture broth (Fig. 2c). sOMV production can be increased 
by a factor 4 at high oxygen concentration, while preserv-
ing growth of the bacteria. Between dissolved oxygen 
concentrations of 150% and 220% air saturation, bacte-
rial growth is affected, illustrated by the declined carbon 
dioxide production rate and lower biomass concentra-
tion (Fig. 2b). Production of OMVs at these levels is not 
preferred.
Next, the changestat was repeated until a dissolved oxy-
gen concentration of 150% after which the setpoint was 
Fig. 1 Influence of the growth rate on OMV release in a N. meningitidis accelerostat. a The optical density (black squares) and the carbon dioxide 
evolution rate of the accelerostat culture (grey line). b The increase of the dilution rate (black line, aD of 0.0055 h
−2), the actual measured dilution 
rate (diamonds). c The resulting specific OMV productivity (mg of total protein (TP) per liter culture of  OD590 per hour ) at different dilution rates for 
the accelerostat (solid circles) and chemostats (open circles). Vesicles were purified from the accelerostat at different dilution rates and the size of 
the purified OMVs is shown in d. Error bars represent the standard deviation of the measurement. The protein composition of the OMVs is analyzed 
by SDS-PAGE (e). Lane 1 contains a molecular weight marker and lane 2–8 contain sOMVs purified at increasing dilution rates
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maintained constant at this value. The culture showed a 
steady state productivity at a similar level as at the cor-
responding oxygen concentration during the changestat 
(Fig.  3a), confirming that the accelerating factor of the 
changestat was sufficiently low to keep the culture in 
steady state. Last, a third changestat culture was done 
where after reaching a dissolved oxygen concentration 
of 150% the setpoint was returned to the starting value 
of 30%. The specific productivity returned to the level at 
the start of the changestats indicating that the changestat 
culture did not induce changes to the bacteria (Fig. 3b). 
Furthermore, the increased oxygen concentrations also 
showed to trigger sOMV release in an E. coli dissolved 
oxygen changestat (Additional file 1: Figure S1). In sum-
mary, it is shown that increased oxygen tension triggers 
OMV formation.
Improved productivity of batch cultures at increased 
oxygen concentrations
The high dissolved oxygen concentration was applied to 
a N. meningitidis batch cultivation to assess the feasibil-
ity of increased sOMV production. A dissolved oxygen 
tension of 100% air saturation was used since this value 
showed increased OMV release while maintaining simi-
lar growth characteristics as at 30% air saturation in the 
changestat (Fig.  2b). Bacteria were grown in chemically 
Fig. 2 The influence of increased dissolved oxygen tension on growth and OMV productivity. a The control of the dissolved oxygen concentration 
in the changestat, where the dissolved oxygen tension was increased by 1% per hour. The effect of the elevated oxygen concentration on the 
growth is shown in b. The carbon dioxide evolution rate (grey) and bacterial biomass density (black squares) is similar for oxygen concentrations up 
to 150% air saturation. c The specific productivity of sOMVs as a function of DO for three replicate cultures. The results for replicate 1 as shown in a, b 
are representative for the two other replicates
Fig. 3 Verification of the dissolved oxygen changestat cultures. One replicate of the N. meningitidis dissolved oxygen changestat was maintained at 
150% air saturation upon reaching this value (a). The specific sOMV productivity remained at 7 × 1010 sOMVs/L culture  OD590 per hour , confirming 
the measurements in the changestats. Another replicate was returned to a steady state at 30% air saturation (b). During 5 dilutions, wash out of the 
OMVs produced at increased oxygen concentrations during the changestat was observed, resulting in a steady with similar productivity (1.6 × 1010 
sOMVs/L culture  OD590 per hour ) to the beginning of the changestat (1.7 × 1010 sOMVs/L culture  OD590 per hour)
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defined medium that results in sOMV release from the 
onset of the stationary phase. The bacterial growth pro-
file was similar for the batch cultures at 30% and 100% 
air saturation, showing the capability of N. meningitidis 
to deal with higher oxygen concentrations (Fig. 4a). The 
higher oxygen concentration triggered an increased 
release of vesicles resulting in a three-fold higher produc-
tivity at the end of the culture compared to the standard 
level of 30% (Fig. 4b). The size of OMVs remains constant 
throughout the culture and is similar between the two 
oxygen concentrations (Fig.  4c). High dissolved oxygen 
levels are therefore a convenient method for increasing 
sOMV production in batch cultures.
Discussion
In this study, we investigated reduced growth rate and 
oxidative stress as triggers to induce sOMV forma-
tion in N. meningitidis. In the accelerostat experiment, 
the growth rate increases linearly with the CER up 
to a growth rate of 0.18  h−1. At higher dilution rates, a 
reduction in CER was observed and the experiment was 
stopped. The maximum specific growth rate of N. men-
ingitidis on this medium is 0.5 h−1 [14] and wash-out is 
thus not expected at this dilution rate. A change in lim-
iting substrate could explain the results at growth rates 
over 0.18  h−1. All chemostats showed depletion of the 
carbon sources glucose and glutamate and the cultures 
were likely carbon limited. A lowered bacterial density 
was observed at reduced bacterial growth rates, that 
could be explained by the increased energy requirement 
for maintenance. The biomass yield on substrate  (Yxs) and 
the maintenance coefficient  (ms) were 0.43  gbiomass.g−1glucose  
and 0.08  gglucose.g−1biomass  h−1, calculated using the 
maintenance model of Pirt [26]. These values were in 
line to the values of aerobic glucose limited chemostat 
cultures reported by Baart et al. (0.44  gbiomass.g−1glucose and 
0.04  gglucose.g−1biomass  h−1 for resp.  Yxs and  ms) [27]. For 
the chemostats there seems to be an increase in specific 
productivity when the growth rate is lowered, where the 
point at the lowest growth rate significantly deviates from 
the accelerostat measurement. Since the lowest growth 
rate is the starting point of the accelerostat, which is cer-
tainly in steady state, this difference is not due to a too 
high acceleration rate in the accelerostat. Together, this 
data shows that reducing the growth rate from 0.18 to 
0.03 h−1 does not have a large effect on OMV productiv-
ity, although due to the contrasting results it is not clear 
if a minor increase in productivity is associated with low-
ered growth rates.
The effect of oxidative stress was assessed by changes-
tat cultures with increasing dissolved oxygen tensions. N. 
meningitidis showed to be capable of handling dissolved 
oxygen concentrations of up to 220% air saturation. 
OMV productivity was increased fourfold in a changes-
tat culture at oxygen concentrations elevated to 150% air 
saturation and threefold in a batch culture controlled at 
100% air saturation in comparison to cultures at 30% air 
saturation. Applying increased dissolved oxygen tension 
on E. coli resulted in a similar increase in sOMV release. 
The production of sOMVs by oxidative stress could be 
triggered in the bioreactor by controlling the oxygen 
concentration in the culture broth, although the exact 
route of OMV induction remains to be elucidated. Oxi-
dative stress triggers sOMV release on top of the known 
genetic mutations that increase OMV formation [14, 19, 
28]. These mutations reduce the linkage between the 
Fig. 4 High dissolved oxygen tension induces OMV release in N. meningitidis batch cultures. Growth curves of N. meningitidis batch cultures 
controlled at 30% (open symbols) and 100% air saturation (solid symbols) show similar growth (a). The increased oxygen concentration showed 
to induce a higher level of vesicle release (b). Graphs are the overlay of two replicate cultures to practically allow for sufficient data points covering 
24 h. The first replicate consists of data points at 0 h to 12 h cultivation and at 24 h cultivation, and the second replicate at 0 h and 15 h to 22 h. 
c The mode size of sOMV particles as measured by NTA in the supernatants from a N. meningitidis batch cultivation at two dissolved oxygen 
concentrations (30% air saturation and 100% air saturation)
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outer membrane and the peptidoglycan layer. Here we 
show the effect of oxidative stress on a rmpM knockout 
strain of N. meningitidis and on a Tol-Pal mutant strain 
of E. coli. Oxidative stress may be a general mechanism 
to induce sOMV release. Applying increased oxygen 
concentrations on a batch culture showed enhanced 
release of OMVs of similar size to OMVs produced in 
a batch culture with sulfur depletion alone, which is an 
indication that oxidative stress is the underlying trigger 
in OMV release triggered by sulfur depletion. Moreover, 
Sabra et  al. showed by electron micrographs that Pseu-
domonas aeruginosa seldom forms membrane vesicles 
under anoxic conditions (~ 0% of air saturation), while 
under extreme oxidative stress conditions (350% of air 
saturation) membrane vesicles were observed [29]. Bio-
logically Neisseria spp. encounter oxidative stress upon 
oxidative bursts of phagocytes [30, 31]. Lappann et  al. 
showed that OMVs of N. meningitidis serve as a decoy 
for the bacteria to circumvent binding of the bacteria 
to neutrophil extracellular traps (NETs) by binding of 
OMVs to the NETs [32]. The response of forming OMVs 
by the bacterium could thus enhance bacterial survival 
by avoiding phagocytosis and NET‐mediated killing. 
During infection, sOMV release probably contributes to 
disease progression and the severity of fulminant menin-
gococcal sepsis [33, 34]. The biological role of OMVs in 
the interaction with phagocytes should gain more inter-
est. Another explanation of OMV release under oxidative 
stress conditions would be that the OMVs alleviates stress 
of the bacterium. This method of stress release could be 
in the form of eliminating misfolded and unfolded pro-
teins, as shown for Pseudomonas aeruginosa [35]. For 
E. coli, OMV formation has been shown advantageous 
to bacterial survival as response to periplasmic protein 
accumulation, and periplasmic peptidoglycan and LPS 
fragment accumulation was found to be associated with 
increased OMV release [36, 37]. Increased OMV release 
as response to increased oxidative stress could be advan-
tageous to the bacterium in a similar manner.
During exponential growth in the batch culture, only 
minor OMV production is observed and high dissolved 
oxygen tension does not induce OMV release in this 
phase. A probable explanation is that N. meningitidis 
can handle the increased oxygen concentrations by their 
metabolism during unlimited growth. Production of oxi-
dative stress is a characteristic of aerobic bacterial growth 
as components of the respiratory chain are oxidized [38]. 
Neisseria spp. are oxidase positive pathogens containing 
a mitochondrial like respiratory chain [39] and typically 
show high levels of respiration [40]. The N. meningitidis 
genome encodes multiple small c-type cytochromes and 
a single terminal cytochrome oxidase of the cbb3 type 
[41–44]. Li et  al. hypothesized that the high respiratory 
capacity of Neisseria spp. and the excess capacity for oxy-
gen reduction acts as defense against endogenous reac-
tive oxygen species (ROS) [43]. SodA and MntC are the 
major effectors involved in the Neisseria spp. oxidative 
stress response [45, 46]. Upon cysteine depletion in batch 
cultures, high oxygen concentrations enhance the pro-
duction of sOMVs. This increased release may be caused 
by a reduction in capacity of handling oxidative stress by 
the oxidative stress defense mechanisms due to cysteine 
limitation.
Our initial results show that OMV size was not affected 
although oxidative stress can cause damage to bacteria. 
In general, increased oxygen concentrations could affect 
bacterial growth and the production of biological com-
pounds [47], as was observed in the changestat culture 
at concentrations over 150% air saturation. Neisseria spp. 
are adapted to ROS production, since reactive oxygen 
species accumulate as byproducts of the aerobic respira-
tion [48, 49]. They thus contain several methods to han-
dle ROS [42, 45]. The changestat experiments showed 
that increased oxygen concentrations can be controlled 
such that growth remains possible. Future work should 
ensure the quality of OMVs produced under oxidative 
stress remains consistent. Promising applications such as 
the additions and stabilization of enzymes on OMVs [50–
52], the study of proteins in their native membrane envi-
ronment [53], or the delivery of drugs packed in OMVs to 
specific cells [54] could also benefit from this production 
method.
Conclusion
In summary, this study shows that the dissolved oxygen 
tension of N. meningitidis cultivations could be used to 
stimulate OMV release by the introduction of oxidative 
stress. Increasing the dissolved oxygen concentration 
of batch cultures from 30 to 150% resulted in a factor 4 
increased specific productivity. The dissolved oxygen 
tension is a well-controlled process parameter to induce 
outer membrane vesicle formation. With this approach, 
OMV production can be improved reducing the produc-
tion costs of OMV-based vaccines and facilitating the use 
of OMVs for other applications.
Methods
Bacterial strains
A recombinant derivate of the Neisseria meningitidis 
serogroup B isolate H44/76 [55] was used in this study. 
The selected strain was a PorA lacking derivate of the 
H44/76 isolate [56]. This strain has a non-encapsulated 
phenotype due to the siaD knockout, lpxL1 deletion to 
attenuate LPS-toxicity, rmpM deletion to improve vesicle 
formation (unless indicated otherwise) and lgtB mutation 
to promote interactions with dendritic cells [14, 57]. This 
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strain was stored in glycerol as working seedlots. All cul-
tivations were performed in chemically defined growth 
medium [27].
For the cultivation with Escherichia coli strain JC8031 
(TolRA) was used [58]. A shaker flask culture was started 
by adding 10  µL of frozen glycerol stock (− 80  °C) to 
100  mL LB medium (Large Capsules: tryptone 10  g/L, 
yeast extract 5  g/L, NaCl 10  g/L, MP Biomedicals) and 
incubating the shaker flask at 37  °C for 16 h. Bioreactor 
cultivations were performed on LB medium without anti-
foam with a maximum stirrer speed of 600 RPM at 37 °C.
Bioreactor cultivations
Batch cultivations were performed in 5 L dished bot-
tom Applikon bioreactors with an H/D ratio of 1.6 
based on total volume. Cultivations were operated with 
3  L working volume on a Pierre Guerin  Trytoni con-
troller. Temperature was controlled at 35 ± 0.5  °C and 
pH was controlled at pH 7.2 ± 0.05 using 1  M HCl and 
1 M NaOH. Dissolved oxygen tension was controlled at 
30% unless indicated otherwise. The membrane cov-
ered polarographic oxygen sensor (InPro 6850i, Mettler 
Toledo) was calibrated at 100% in air-saturated sterile 
growth medium of 35  °C. In the first phase of the cul-
tivation, the dissolved oxygen tension is controlled by 
increasing the agitation rate (300–1000 RPM) followed 
by increasing the fraction of oxygen in the headspace 
aeration (1  L/min) by the addition of pure oxygen. The 
agitation rate of the 100% air saturation cultures was 
fixed at 1000 RPM directly after inoculation after which 
the oxygen tension was controlled by the addition of pure 
oxygen in the headspace. Samples were taken for optical 
density measurements and used for nutrient and sOMV 
measurements after sterile filtration (0.22 µm pore-size) 
and storage at 4 °C. Off-gas composition was analyzed by 
a Thermo Prima δb process mass spectrometer.
Chemostat cultivations
Continuous cultivations were performed in a similar 
setup as the batch cultivation setup. The working volume 
of the 5 L bioreactor was decreased from 3.0 to 2.0 L to 
reduce the feed medium required for the experiments. 
The vessel was equipped with a medium inlet and two 
outlet pipes, one submerged in the cultivation broth at 
the height of the stirrer and one directly at the liquid–gas 
interphase. The latter allowed the control of the work-
ing volume to be exactly 2.0 L at a fixed maximum stir-
rer speed, independent of foaming. The weight of the 
bioreactor, the feed medium and the pH titrant solu-
tions was measured by balances and used for verifica-
tion of the dilution rate. Samples were taken for optical 
density measurements and off-gas analysis was similar to 
the batch cultivation. The bioreactor was controlled with 
the same control loops as used in the batch cultivations. 
After 8 h of growth the feed and the bleed pumps were 
started to initiate a continuous culture. Steady state of 
the culture was assumed based on stable bacterial density 
values and stable carbon dioxide emission for at least 3 
dilutions of the bioreactor volume.
Accelerostat and dissolved oxygen changestat cultivation
An accelerostat was started from a chemostat fermenta-
tion in steady state at D = 0.03 h−1, operated as described 
in the previous section, by increasing the dilution rate lin-
early with  aD = 0.0055 h−2. The dilution rate was changed 
by increasing the medium inflow rate and equally increas-
ing the broth outflow rate. From the culture broth, 50 mL 
samples were drawn to purify sOMVs. The samples were 
centrifuged at 4000×g for 30 min at 4 °C and the sterile 
filtered supernatants (Nalgene RapidFlow 0.2  µm pore-
size PES filter unit) were concentrated on 100 kDa cut-off 
spin filters. The concentrated sOMVs were washed with 
3% sucrose buffered by 10 mM TrisHCl (pH 7.4) to wash 
out contaminating proteins. Next, the diafiltrated sOMVs 
were centrifuged at 125.000×g for 2 h. The sOMV con-
taining pellet was dissolved in 1 mL 10 mM TrisHCl (pH 
7.4) with 3% sucrose.
The dissolved oxygen tension changestat was started 
from a chemostat culture. For this, a continuous cul-
ture in steady state with µ = 0.04  h−1 was obtained as 
described previously. During this steady state, the oxygen 
concentration was controlled at 30% air saturation, the 
starting point for the changestat. From the start of the 
changestat, the oxygen concentration was increased lin-
early with  aDOT = 1.0%/h.
Escherichia coli JC8031 (TolRA) was used for the dis-
solved oxygen tension changestat of E. coli [58]. A shaker 
flask culture was started by adding 10 µL of frozen glyc-
erol stock (− 80  °C) to 100 mL LB medium (Large Cap-
sules: tryptone 10 g/L, yeast extract 5 g/L, NaCl 10 g/L, 
MP Biomedicals) and incubating the shaker flask at 37 °C 
for 16  h. Bioreactor cultivations were performed on LB 
medium without antifoam with a maximum stirrer speed 
of 600 RPM at 37 °C.
Quantification of sOMVs
Culture samples were sterile filtered (0.22 µm pore-size) 
before the sOMV were measured. sOMV concentra-
tion was measured with a phospholipid specific probe 
FM 4-64 (SynaptoRed C2, Biotium) by mixing 50  µL of 
2- to 50-fold diluted samples with 50 µL of dye solution 
(0.05 mM FM 4-64). Fluorescence was measured directly 
after mixing this solution using a plate fluorometer (Syn-
ergy MX, Biotek ex480, em650). The concentration of 
sOMV in the culture supernatants was calculated from 
a calibration curve which was based on the responses of 
Page 8 of 10Gerritzen et al. Microb Cell Fact  (2018) 17:157 
the standards (sOMV corresponding with 0–2.5  mg/L 
total protein). In the changestat experiments, nanopar-
ticle tracking analysis [59] was used for sOMV quanti-
fication. Static measurements (10 captures of 30 s) were 
made on a NanoSight NS500 with 488 nm laser module 
and sCMOS camera, that was calibrated with the con-
centration upgrade [60]. Temperature was controlled at 
25 °C and captures were analyzed with the NTA 3.2 soft-
ware build 3.2.16. Automated flow measurements were 
made as described previously [61].
OMV size was assessed by dynamic light scattering 
in a Zetasizer Nano-ZS with Zetasizer 7.11 software 
(Malvern Instruments). Measurements were performed 
using a SOP that takes three measurements in backscat-
ter mode, with auto measurement duration and “seek for 
optimal position” as positioning setting. The sample was 
assumed to be protein with a refractive index of 1.450 
and 0.001 absorption, in water as dispersant with a vis-
cosity of 0.8872 cP and refractive index of 1.330. Data 
was processed with the normal analysis model.
Sds‑page
Purified OMVs were assessed for total protein content by 
the Lowry protein assay using Peterson’s modification. 
OMVs corresponding to 4 µg of protein were loaded on 
a precast polyacrylamide gel (Lonza) to perform SDS-
gel electrophoresis. The gel was stained with InstantBlue 
protein stain (Expedeon).
Additional file
Additional file 1: Figure S1. Increased dissolved oxygen tension triggers 
OMV release in E. coli. Changestat of E. coli (A) shows growth at dis-
solved oxygen tensions up to 200% air saturation in a changestat with 
 aDOT = 1.5%/h. OMV release is directly related to the increased oxygen 
concentration.
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